Skip to main page content
U.S. flag

An official website of the United States government

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Search Results

203 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
The comparison of weekly and three-weekly cisplatin chemotherapy concurrent with radiotherapy in patients with previously untreated inoperable non-metastatic squamous cell carcinoma of the head and neck.
Uygun K, Bilici A, Karagol H, Caloglu M, Cicin I, Aksu G, Fayda M, Uzunoglu S. Uygun K, et al. Cancer Chemother Pharmacol. 2009 Aug;64(3):601-5. doi: 10.1007/s00280-008-0911-7. Epub 2009 Jan 3. Cancer Chemother Pharmacol. 2009. PMID: 19123002 Clinical Trial.
Effect of maximum-tolerated doses and low-dose metronomic chemotherapy on serum vascular endothelial growth factor and thrombospondin-1 levels in patients with advanced nonsmall cell lung cancer.
Tas F, Duranyildiz D, Soydinc HO, Cicin I, Selam M, Uygun K, Disci R, Yasasever V, Topuz E. Tas F, et al. Among authors: uygun k. Cancer Chemother Pharmacol. 2008 Apr;61(5):721-5. doi: 10.1007/s00280-007-0526-4. Epub 2007 Jun 7. Cancer Chemother Pharmacol. 2008. PMID: 17554539 Clinical Trial.
203 results